Pharmacological therapy in critically ill patients with peripheral and concomitant arteriopathy

Terapia farmacologica nel paziente critico con arteriopatia periferica e concomitante

Authors

  • Nicola Troisi UO Chirurgia Vascolare, Azienda Toscana Centro, Ospedale San Giovanni di Dio, Firenze - Italy
  • Antonio Trani UOC Chirurgia Vascolare ed Endovascolare, Azienda Ospedaliera “San Carlo”, Potenza - Italy
  • Pierluigi Antonino Cappiello UOC Chirurgia Vascolare ed Endovascolare, Azienda Ospedaliera “San Carlo”, Potenza - Italy

DOI:

https://doi.org/10.19156/abtpn.2018.0068

Keywords:

Peripheral arteriopathy, Cilostazol, Iloprost, Cardiovascular risk

Abstract

Peripheral arterial disease is one of the most frequent clinical manifestations of atherosclerotic disease. The clinical picture of critical ischemia of the lower limbs is often burdened by high mortality and the risk of limb amputation. The direct and indirect prostanoids, and in particular iloprost and cilostazol, are effective in the medical treatment of peripheral arterial disease. We describe here five clinical cases in which iloprost and cilostazol have been successfully administered in arterial patients with various concomitant cardiovascular diseases, highlighting a good safety profile in relation to the cardiocascular risk profile (Cardiology).

Downloads

Download data is not yet available.

Downloads

Published

2018-09-15

How to Cite

Troisi, N., Trani, A., & Cappiello, P. A. (2018). Pharmacological therapy in critically ill patients with peripheral and concomitant arteriopathy: Terapia farmacologica nel paziente critico con arteriopatia periferica e concomitante. AboutOpen, 4(1), 166–173. https://doi.org/10.19156/abtpn.2018.0068